Cost and clinical flow of point‐of‐care urine tenofovir testing for treatment monitoring among people living with HIV initiating ART in South Africa
Abstract Introduction Point‐of‐care (POC) urine tenofovir (TFV) tests can provide timely information regarding antiretroviral therapy (ART) adherence to support management of HIV treatment in clinics. However, there are limited data on the costs and feasibility of integrating POC testing into HIV cl...
Saved in:
Main Authors: | Melody Wang, Pravikrishnen Moodley, Mlungisi Khanyile, Elliot Bulo, Makhosazane Zondi, Keshani Naidoo, Yukteshwar Sookrajh, Jienchi Dorward, Monica Gandhi, Nigel Garrett, Paul K. Drain, Monisha Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-07-01
|
Series: | Journal of the International AIDS Society |
Subjects: | |
Online Access: | https://doi.org/10.1002/jia2.70004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study)
by: Roberta Gagliardini, et al.
Published: (2025-09-01) -
Metabolic Health Consequences of Switching to the Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir Plus Lamivudine Regimens in Virologically Suppressed People Living with HIV Aged > 40 Years: A Retrospective Real-World Study
by: Shi J, et al.
Published: (2025-05-01) -
Successful viral suppression in a two-year-old child with human immunodeficiency virus infection treated with bictegravir/emtricitabine/tenofovir alafenamide
by: Coskun Ekemen, et al.
Published: (2025-07-01) -
Age‐specific all‐cause mortality rates among adolescents and youth living with and without HIV: Evidence from a cohort study in South Africa
by: Siyanai Zhou, et al.
Published: (2025-06-01) -
The Public Health Impact of Foreign Aid Withdrawal by the United States Government and Its Implications for ARVs, Preexposure, and Postexposure Prophylaxis Medications in South Africa and Nigeria
by: Samuel Chima Ugbaja, et al.
Published: (2025-06-01)